Работы, на которые ссылается эта работа

Работ: 321

Работа: COVID-19 Vaccines - Current State and Perspectives

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi +97
Статья2020Цитирований: 3
ABI
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Tom T. Shimabukuro, Michael Nguyen, David Martin +1
Обзорная статья2015Цитирований: 3
ABI
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes
Dimitrios Karussis, Panayiota Petrou
Обзорная статья2013Цитирований: 3
ABI
COVID-19 and Eye
Mrittika Sen, Santosh G Honavar, Namrata Sharma +1
Обзорная статья2021Цитирований: 3
ABI
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni, Kerstin Kläser, Anna May +25
Статья2021Цитирований: 3
ABI
Без названия
ДругоеЦитирований: 2
ABI
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini +4
Обзорная статья2021Цитирований: 2
ABI
Vaccine hesitancy in the era of COVID-19
Gianmarco Troiano, A Nardi
Обзорная статья2021Цитирований: 2
ABI
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
Julio S. Solís Arce, Shana S. Warren, Niccolò F. Meriggi +71
Статья2021Цитирований: 2
ABI
Circular RNA: metabolism, functions and interactions with proteins
Zhou Wei-yi, Zerong Cai, Jia Liu +3
Обзорная статья2020Цитирований: 2
ABI
Milk of Cow and Goat, Immunized by Recombinant Protein Vaccine ZF-UZ-VAC2001(Zifivax), Contains Neutralizing Antibodies Against SARS-CoV-2 and Remains Active After Standard Milk Pasteurization
Victoria Garib, Stefani Katsamaki, Shahlo Тurdikulova +9
СтатьяSARS-CoV-2 and COVID-19 ResearchFrontiers in Nutrition2022Цитирований: 2
ABI
A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants
Linglei Jiang, Tom A. P. Driedonks, Wouter S. P. Jong +22
Статья2022Цитирований: 2
ABI
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
Carmen Schwechheimer, Meta Kuehn
Обзорная статья2015Цитирований: 2
ABI
Direct Gene Transfer into Mouse Muscle in Vivo
Jon A. Wolff, Robert W. Malone, Phillip Williams +4
Статья1990Цитирований: 2
ABI
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases
Devon E. McMahon, Erin Amerson, Misha Rosenbach +11
Статья2021Цитирований: 2
ABI
Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
Luca Spiro Santovito, Graziano Pinna
Другое2021Цитирований: 2
ABI
The lightning-fast quest for COVID vaccines — and what it means for other diseases
Philip Ball
Статья2020Цитирований: 2
ABI
Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi
Steven Munharo, Symon Fidelis Nayupe, Patrick Mbulaje +6
Статья2020Цитирований: 2
ABI
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future
Fausto Baldanti, Nirmal Kumar Ganguly, Guiqiang Wang +6
Обзорная статья2022Цитирований: 2
ABI
Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Статья2022Цитирований: 2
ABI
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan +18
Статья2020Цитирований: 2
ABI
Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
Punam Mangtani, Ibrahim Abubakar, Cono Ariti +8
Обзорная статья2013Цитирований: 2
ABI
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin, Katja Fink, Michael Schmid +6
Статья2020Цитирований: 2
ABI
A vulnerability index for the management of and response to the COVID-19 epidemic in India: an ecological study
Rajib Acharya, Akash Porwal
Статья2020Цитирований: 2
ABI
Vaccines for COVID-19
John S. Tregoning, E. Sherwood Brown, Hannah M. Cheeseman +7
Обзорная статья2020Цитирований: 2
ABI